FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to veterinary science and concerns adjuvant compositions containing the combination Quil A or its purified fraction, cholesterol, dimethyldioctadecyl ammonium (DDA) bromide, polyacrylic acid (CARBOPOL) and CpG and/or N-(2-deoxy-2-L-leucylamino-β-D-glucopyranosyl)-N-octadecyl dodecane amide acetate; a method for preparing such adjuvant compositions; and using these adjuvant compositions in immunogenic and vaccine compositions with various antigens.
EFFECT: group of inventions provides a synergetic effect between the above ingredients of the composition.
20 cl, 25 ex, 1 dwg, 30 tbl
Title | Year | Author | Number |
---|---|---|---|
MUCROFLUIDIC OIL-IN-WATER EMULSION AND VACCINE COMPOSITIONS | 2004 |
|
RU2541809C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2730011C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2816849C2 |
LIPOSOMAL ADJUVANT COMPOSITIONS | 2016 |
|
RU2736642C2 |
VACCINE AGAINST INFECTIOUS BRONCHITIS | 2017 |
|
RU2781143C2 |
COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
OIL-BASED ADJUVANTS | 2014 |
|
RU2816851C2 |
MICROFLUIDISED OIL-IN-WATER EMULSIONS AND VACCINE COMPOSITIONS | 2005 |
|
RU2347586C2 |
COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
MYCOPLASMA HYOPNEUMONIAE VACCINE | 2013 |
|
RU2644254C2 |
Authors
Dates
2014-03-27—Published
2009-06-24—Filed